These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23583496)

  • 1. Multiplexed immunoassay to assess Shigella-specific antibody responses.
    Kaminski RW; Clarkson K; Kordis AA; Oaks EV
    J Immunol Methods; 2013 Jul; 393(1-2):18-29. PubMed ID: 23583496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development, Interlaboratory Evaluations, and Application of a Simple, High-Throughput
    Nahm MH; Yu J; Weerts HP; Wenzel H; Tamilselvi CS; Chandrasekaran L; Pasetti MF; Mani S; Kaminski RW
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898979
    [No Abstract]   [Full Text] [Related]  

  • 4. Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of
    Turbyfill KR; Clarkson KA; Vortherms AR; Oaks EV; Kaminski RW
    mSphere; 2018; 3(2):. PubMed ID: 29600284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine.
    Riddle MS; Kaminski RW; Williams C; Porter C; Baqar S; Kordis A; Gilliland T; Lapa J; Coughlin M; Soltis C; Jones E; Saunders J; Keiser PB; Ranallo RT; Gormley R; Nelson M; Turbyfill KR; Tribble D; Oaks EV
    Vaccine; 2011 Sep; 29(40):7009-19. PubMed ID: 21787825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum antibody responses against shigella lipopolysaccharides and invasion plasmid-coded antigens in shigella infected Swedish patients.
    Li A; Rong ZC; Ekwall E; Forsum U; Lindberg AA
    Scand J Infect Dis; 1993; 25(5):569-77. PubMed ID: 8284641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides.
    Oberhelman RA; Kopecko DJ; Salazar-Lindo E; Gotuzzo E; Buysse JM; Venkatesan MM; Yi A; Fernandez-Prada C; Guzman M; León-Barúa R
    Infect Immun; 1991 Jul; 59(7):2341-50. PubMed ID: 2050402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination.
    Cohen D; Orr N; Robin G; Slepon R; Ashkenazi S; Ashkenazi I; Shemer J
    Clin Diagn Lab Immunol; 1996 Jul; 3(4):451-5. PubMed ID: 8807212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel
    Ndungo E; Randall A; Hazen TH; Kania DA; Trappl-Kimmons K; Liang X; Barry EM; Kotloff KL; Chakraborty S; Mani S; Rasko DA; Pasetti MF
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30068560
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial.
    McKenzie R; Walker RI; Nabors GS; Van De Verg LL; Carpenter C; Gomes G; Forbes E; Tian JH; Yang HH; Pace JL; Jackson WJ; Bourgeois AL
    Vaccine; 2006 May; 24(18):3735-45. PubMed ID: 16095766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shigella IpaB and IpaD displayed on L. lactis bacterium-like particles induce protective immunity in adult and infant mice.
    Heine SJ; Franco-Mahecha OL; Chen X; Choudhari S; Blackwelder WC; van Roosmalen ML; Leenhouts K; Picking WL; Pasetti MF
    Immunol Cell Biol; 2015 Aug; 93(7):641-52. PubMed ID: 25776843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning and biologically active production of IpaD N-terminal region.
    Hesaraki M; Saadati M; Honari H; Olad G; Heiat M; Malaei F; Ranjbar R
    Biologicals; 2013 Jul; 41(4):269-74. PubMed ID: 23731655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes.
    Heine SJ; Diaz-McNair J; Andar AU; Drachenberg CB; van de Verg L; Walker R; Picking WL; Pasetti MF
    J Immunol; 2014 Feb; 192(4):1630-40. PubMed ID: 24453241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the functional B-cell epitopes of
    Li S; Zhang W
    Appl Environ Microbiol; 2024 Aug; 90(8):e0098824. PubMed ID: 39082807
    [No Abstract]   [Full Text] [Related]  

  • 15. A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection.
    Phalipon A; Tanguy M; Grandjean C; Guerreiro C; Bélot F; Cohen D; Sansonetti PJ; Mulard LA
    J Immunol; 2009 Feb; 182(4):2241-7. PubMed ID: 19201878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-protection provided by live Shigella mutants lacking major antigens.
    Szijártó V; Hunyadi-Gulyás E; Emődy L; Pál T; Nagy G
    Int J Med Microbiol; 2013 May; 303(4):167-75. PubMed ID: 23567193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An approach to chimeric subunit immunogen provides efficient protection against toxicity, type III and type v secretion systems of Shigella.
    Felegary A; Nazarian S; Kordbacheh E; Fathi J; Minae ME
    Int Immunopharmacol; 2021 Nov; 100():108132. PubMed ID: 34508943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp.
    Oaks EV; Hale TL; Formal SB
    Infect Immun; 1986 Jul; 53(1):57-63. PubMed ID: 3721580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IpaD-loaded N-trimethyl Chitosan Nanoparticles Can Efficiently Protect Guinea Pigs against Shigella flexneri.
    Akbari MR; Saadati M; Honari H; Ghorbani HM
    Iran J Immunol; 2019 Sep; 16(3):212-224. PubMed ID: 31552830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a.
    Shim DH; Chang SY; Park SM; Jang H; Carbis R; Czerkinsky C; Uematsu S; Akira S; Kweon MN
    Vaccine; 2007 Jun; 25(25):4828-36. PubMed ID: 17507120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.